What is Beaconcure?
Beaconcure is a technology company dedicated to enhancing the efficiency and accuracy of clinical trial data validation for pharmaceutical companies and Contract Research Organizations (CROs). Their proprietary 'Verify' platform automates the detection of data inconsistencies during the Quality Control (QC) process, thereby reducing handling time and minimizing the risk of errors in regulatory submissions. Developed in collaboration with Pfizer, Beaconcure's algorithms are designed to support a wide range of therapeutic areas and study sizes, enabling clients to accelerate the introduction of new treatments to patients and maintain competitive advantages in intellectual property protection and market entry.
How much funding has Beaconcure raised?
Beaconcure has raised a total of $14M across 1 funding round:
Series B
$14M
Series B (2023): $14M, investors not publicly disclosed
What's next for Beaconcure?
The recent major strategic investment signifies a critical growth phase for Beaconcure, likely enabling the company to scale its operations, expand its technological capabilities, and broaden its market reach. This backing suggests confidence from investors in Beaconcure's ability to address key challenges in the pharmaceutical R&D pipeline, potentially leading to further innovation in clinical trial technology and a faster path to market for life-saving therapies. The company is poised to solidify its position as a leader in regulatory compliance and data integrity solutions.
See full Beaconcure company page
